company background image
500288 logo

Morepen Laboratories BSE:500288 Stock Report

Last Price

₹55.57

Market Cap

₹28.4b

7D

-5.7%

1Y

88.6%

Updated

14 Jul, 2024

Data

Company Financials

Morepen Laboratories Limited

BSE:500288 Stock Report

Market Cap: ₹28.4b

500288 Stock Overview

Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally.

500288 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 500288 from our risk checks.

Morepen Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Morepen Laboratories
Historical stock prices
Current Share Price₹55.57
52 Week High₹60.75
52 Week Low₹28.51
Beta1.45
11 Month Change-0.93%
3 Month Change25.16%
1 Year Change88.63%
33 Year Change-16.81%
5 Year Change233.75%
Change since IPO-49.94%

Recent News & Updates

Recent updates

Shareholder Returns

500288IN PharmaceuticalsIN Market
7D-5.7%0.7%0.5%
1Y88.6%51.1%45.1%

Return vs Industry: 500288 exceeded the Indian Pharmaceuticals industry which returned 51.1% over the past year.

Return vs Market: 500288 exceeded the Indian Market which returned 45.1% over the past year.

Price Volatility

Is 500288's price volatile compared to industry and market?
500288 volatility
500288 Average Weekly Movement6.7%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 500288 has not had significant price volatility in the past 3 months.

Volatility Over Time: 500288's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19841,649Sushil Suriwww.morepen.com

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides fever X for fever; Pain X for pain; Fiber-X, a sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals.

Morepen Laboratories Limited Fundamentals Summary

How do Morepen Laboratories's earnings and revenue compare to its market cap?
500288 fundamental statistics
Market cap₹28.41b
Earnings (TTM)₹961.60m
Revenue (TTM)₹17.04b

29.5x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
500288 income statement (TTM)
Revenue₹17.04b
Cost of Revenue₹10.97b
Gross Profit₹6.08b
Other Expenses₹5.12b
Earnings₹961.60m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.88
Gross Margin35.67%
Net Profit Margin5.64%
Debt/Equity Ratio3.4%

How did 500288 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.